Key facts
- This page summarizes Jonathon Thomas Gut's Form 3 filing for Imricor Medical Systems, Inc..
- 0 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 18 May 2026, 17:33.
Jonathon Thomas Gut - 18 May 2026 Form 3 Insider Report for Imricor Medical Systems, Inc.
- Reporting relationship
- VP of Finance and CFO
- Issuer ticker
- N/A
- Reported as of
- 18 May 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Jonathon Thomas Gut
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Jonathon Thomas Gut filed Form 3 for Imricor Medical Systems, Inc. on 18 May 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002132970
Primary reporting owner
Gut Jonathon Thomas
- Relationship
- VP of Finance and CFO
- Address
- C/O IMRICOR MEDICAL SYSTEMS, INC., 400 GATEWAY BLVD, BURNSVILLE
- Signature
- /s/ Jonathon Thomas Gut
- Signature date
- 18 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
No ticker
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 40,000
- Date
- 18 May 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No ticker
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 May 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 100,000
- Exercise price
- $1.96
- Footnotes
- F2
No ticker
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 May 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 25,300
- Exercise price
- $1.55
- Footnotes
- F3
No ticker
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 May 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 180,000
- Exercise price
- $0.6500
- Footnotes
- F4
No ticker
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 May 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 212,906
- Exercise price
- $0.3000
- Footnotes
- F5
No ticker
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 May 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 59,404
- Exercise price
- $1.07
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The shares reported in column 2 are held jointly with Michelle Gut.
Footnote F2
This option was granted on October 7, 2020, and vested in multiple installments over approximately four years from the grant date. This option is 100% vested.
Footnote F3
This option was granted on May 5, 2021, and vested in multiple installments over approximately four years from the grant date. This option is 100% vested.
Footnote F4
This option was granted on February 10, 2022, and vests 25% per year in equal installments, starting on July 1, 2023. One fourth of this option vested and became exercisable on each of July 1, 2023, July 1, 2024, and July 1, 2025, and one fourth of this option will vest and become exercisable on July 1, 2026.
Footnote F5
Represents the vested portion of the option granted on May 15, 2024. This portion vested upon the achievement of a certain performance milestone. A portion of this option is not reported here because it remains subject to performance-based vesting conditions that have not yet been achieved.
Footnote F6
Represents the vested portion of the option granted on May 14, 2025. This portion vested upon the achievement of a certain performance milestone. A portion of this option is not reported here because it remains subject to performance-based vesting conditions that have not yet been achieved.